La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.

Identifieur interne : 002976 ( Main/Exploration ); précédent : 002975; suivant : 002977

Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.

Auteurs : Thomas J. Montine [États-Unis] ; Ke Li ; Daniel P. Perl ; Douglas Galasko

Source :

RBID : pubmed:16157919

Descripteurs français

English descriptors

Abstract

High levels of beta-methylamino-l-alanine (BMAA), a putative neurotoxin, have been reported in brain samples from Chamorros and patients with Alzheimer disease (AD) from western Canada. The authors assayed free BMAA in the brains of five control subjects and five patients with AD from the US Pacific Northwest as well as Chamorros with and without Parkinson-dementia complex. In contrast to others, they detected no free BMAA in any of these samples.

DOI: 10.1212/01.wnl.0000174523.62022.52
PubMed: 16157919


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.</title>
<author>
<name sortKey="Montine, Thomas J" sort="Montine, Thomas J" uniqKey="Montine T" first="Thomas J" last="Montine">Thomas J. Montine</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pathology, University of Washington, Seattle, WA 98104, USA. tmontine@u.washington.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Washington, Seattle, WA 98104</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
<author>
<name sortKey="Li, Ke" sort="Li, Ke" uniqKey="Li K" first="Ke" last="Li">Ke Li</name>
</author>
<author>
<name sortKey="Perl, Daniel P" sort="Perl, Daniel P" uniqKey="Perl D" first="Daniel P" last="Perl">Daniel P. Perl</name>
</author>
<author>
<name sortKey="Galasko, Douglas" sort="Galasko, Douglas" uniqKey="Galasko D" first="Douglas" last="Galasko">Douglas Galasko</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16157919</idno>
<idno type="pmid">16157919</idno>
<idno type="doi">10.1212/01.wnl.0000174523.62022.52</idno>
<idno type="wicri:Area/PubMed/Corpus">001233</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001233</idno>
<idno type="wicri:Area/PubMed/Curation">001233</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001233</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001233</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001233</idno>
<idno type="wicri:Area/Ncbi/Merge">000575</idno>
<idno type="wicri:Area/Ncbi/Curation">000575</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000575</idno>
<idno type="wicri:Area/Main/Merge">002C96</idno>
<idno type="wicri:Area/Main/Curation">002976</idno>
<idno type="wicri:Area/Main/Exploration">002976</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.</title>
<author>
<name sortKey="Montine, Thomas J" sort="Montine, Thomas J" uniqKey="Montine T" first="Thomas J" last="Montine">Thomas J. Montine</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pathology, University of Washington, Seattle, WA 98104, USA. tmontine@u.washington.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Washington, Seattle, WA 98104</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
<author>
<name sortKey="Li, Ke" sort="Li, Ke" uniqKey="Li K" first="Ke" last="Li">Ke Li</name>
</author>
<author>
<name sortKey="Perl, Daniel P" sort="Perl, Daniel P" uniqKey="Perl D" first="Daniel P" last="Perl">Daniel P. Perl</name>
</author>
<author>
<name sortKey="Galasko, Douglas" sort="Galasko, Douglas" uniqKey="Galasko D" first="Douglas" last="Galasko">Douglas Galasko</name>
</author>
</analytic>
<series>
<title level="j">Neurology</title>
<idno type="eISSN">1526-632X</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Alzheimer Disease (chemically induced)</term>
<term>Alzheimer Disease (metabolism)</term>
<term>Alzheimer Disease (physiopathology)</term>
<term>Amino Acids, Diamino (analysis)</term>
<term>Amino Acids, Diamino (metabolism)</term>
<term>Amyotrophic Lateral Sclerosis (chemically induced)</term>
<term>Amyotrophic Lateral Sclerosis (metabolism)</term>
<term>Amyotrophic Lateral Sclerosis (physiopathology)</term>
<term>Brain (metabolism)</term>
<term>Brain (pathology)</term>
<term>Brain (physiopathology)</term>
<term>Brain Chemistry (physiology)</term>
<term>Canada</term>
<term>Environmental Exposure</term>
<term>Female</term>
<term>Guam</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinsonian Disorders (chemically induced)</term>
<term>Parkinsonian Disorders (metabolism)</term>
<term>Parkinsonian Disorders (physiopathology)</term>
<term>Reproducibility of Results</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Amino Acids, Diamino</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Canada</term>
<term>Guam</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Amino Acids, Diamino</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Brain</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Brain Chemistry</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Brain</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Environmental Exposure</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Reproducibility of Results</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">High levels of beta-methylamino-l-alanine (BMAA), a putative neurotoxin, have been reported in brain samples from Chamorros and patients with Alzheimer disease (AD) from western Canada. The authors assayed free BMAA in the brains of five control subjects and five patients with AD from the US Pacific Northwest as well as Chamorros with and without Parkinson-dementia complex. In contrast to others, they detected no free BMAA in any of these samples.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Washington (État)</li>
</region>
<settlement>
<li>Seattle</li>
</settlement>
<orgName>
<li>Université de Washington</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Galasko, Douglas" sort="Galasko, Douglas" uniqKey="Galasko D" first="Douglas" last="Galasko">Douglas Galasko</name>
<name sortKey="Li, Ke" sort="Li, Ke" uniqKey="Li K" first="Ke" last="Li">Ke Li</name>
<name sortKey="Perl, Daniel P" sort="Perl, Daniel P" uniqKey="Perl D" first="Daniel P" last="Perl">Daniel P. Perl</name>
</noCountry>
<country name="États-Unis">
<region name="Washington (État)">
<name sortKey="Montine, Thomas J" sort="Montine, Thomas J" uniqKey="Montine T" first="Thomas J" last="Montine">Thomas J. Montine</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002976 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002976 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16157919
   |texte=   Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16157919" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022